| Literature DB >> 10393694 |
K Kuwano1, N Hagimoto, M Kawasaki, T Yatomi, N Nakamura, S Nagata, T Suda, R Kunitake, T Maeyama, H Miyazaki, N Hara.
Abstract
The Fas ligand is predominantly expressed in activated T lymphocytes and is one of the major effector molecules of cytotoxic T lymphocytes and natural killer cells. Previously, we found excessive apoptosis of epithelial cells and infiltrating lymphocytes expressing Fas ligand mRNA in the lung tissue of bleomycin-induced pulmonary fibrosis in mice. Here we demonstrated that the administration of a soluble form of Fas antigen or anti-Fas ligand antibody prevented the development of this model and that lpr and gld mice were resistant against the induction of pneumopathy. These results suggest that the Fas-Fas ligand pathway plays an essential role in the development of pulmonary fibrosis and that preventing this pathway could have therapeutic value in lung injury and fibrosis.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10393694 PMCID: PMC408400 DOI: 10.1172/JCI5628
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808